- Home
- ZLAB vs HBANL Comparison
ZLAB vs HBANL Comparison
Compare ZLAB & HBANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- HBANL
- Stock Information
- Founded
- ZLAB 2013
- HBANL N/A
- Country
- ZLAB Cayman Islands
- HBANL United States
- Employees
- ZLAB N/A
- HBANL 19932
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- HBANL Major Banks
- Sector
- ZLAB Health Care
- HBANL Finance
- Exchange
- ZLAB Nasdaq
- HBANL Nasdaq
- Market Cap
- ZLAB 3.5B
- HBANL N/A
- IPO Year
- ZLAB 2017
- HBANL N/A
- Fundamental
- Price
- ZLAB $32.00
- HBANL $25.00
- Analyst Decision
- ZLAB Buy
- HBANL
- Analyst Count
- ZLAB 4
- HBANL 0
- Target Price
- ZLAB $47.37
- HBANL N/A
- AVG Volume (30 Days)
- ZLAB 1.7M
- HBANL N/A
- Earning Date
- ZLAB 05-08-2025
- HBANL N/A
- Dividend Yield
- ZLAB N/A
- HBANL N/A
- EPS Growth
- ZLAB N/A
- HBANL N/A
- EPS
- ZLAB N/A
- HBANL N/A
- Revenue
- ZLAB $398,988,000.00
- HBANL N/A
- Revenue This Year
- ZLAB $45.57
- HBANL N/A
- Revenue Next Year
- ZLAB $47.91
- HBANL N/A
- P/E Ratio
- ZLAB N/A
- HBANL N/A
- Revenue Growth
- ZLAB 49.59
- HBANL N/A
- 52 Week Low
- ZLAB $15.65
- HBANL N/A
- 52 Week High
- ZLAB $39.77
- HBANL N/A
- Technical
- Relative Strength Index (RSI)
- ZLAB 49.83
- HBANL 49.28
- Support Level
- ZLAB $28.34
- HBANL $24.54
- Resistance Level
- ZLAB $34.59
- HBANL $25.03
- Average True Range (ATR)
- ZLAB 2.12
- HBANL 0.43
- MACD
- ZLAB 0.40
- HBANL 0.04
- Stochastic Oscillator
- ZLAB 74.98
- HBANL 73.91
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About HBANL Huntington Bancshares Incorporated Depositary Shares Each Representing a 1/40th Interest in a Share of 6.875% Series J Non-Cumulative Perpetual Preferred Stock
Huntington is a regional US bank with around $200 billion in assets (as of 2024) and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.